Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBP in Relapsed or Refractory Multiple Myeloma
NCT01002703Phase 2Unknown
- Sponsor
- Leipzig University
- Start
- Sep 2009
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in multiple myeloma (MM), sponsored by Leipzig University. Status: unknown.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01002703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01002703.